Skip to main content

Advertisement

SpringerLink
Log in

Aortic pulse wave velocity in haemodialysis patients is associated with the prescription of active vitamin D analogues

  • Original Article
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

Abstract

Background

Cardiovascular disease remains the most common cause of death for haemodialysis patients. In addition to traditional cardiovascular risk factors, haemodialysis patients have additional risk factors, including vascular calcification. Pulse wave velocity (PWV) is a measurement of arterial stiffness, and we wished to determine whether PWV is affected by different factors in haemodialysis patients compared to the general population.

Methods

Aortic PWV was measured in 303 adult patients attending for routine outpatient dialysis.

Results

303 patients, 63.4 % male, mean age 68.5 ± 15.8 years, 47.5 % diabetic with a body mass index of 25.8 ± 5.3 kg/m2, were studied. Systolic blood pressure (SBP) was 148.7 ± 28.6 mmHg and diastolic 80.4 ± 15.3 mmHg. Aortic PWV was 9.73 ± 2.08 m/s, and was correlated with SBP (β 0.015, F 5.29, p = 0.023), log serum parathyroid hormone (PTH) (β 1.58, F 13.85, p < 0.001) and prescription of alfacalcidol (β −1.11, F 6.81, p = 0.010). 197 patients had corresponding ECHO cardiograms, and in this cohort PWV was associated with SBP (β 0.017, F 7.49, p = 0.006), log serum parathyroid hormone (β 0.85, F 5.99, p < 0.015) and prescription of alfacalcidol (β −0.8, F 4.18, p = 0.042), left ventricular mass index (LVMI) (β 0.01, F 11.4, p = 0.001), and log serum triglycerides (β 1.43, F 4.79, p = 0.03).

Conclusions

We found that PWV, a measurement of arterial stiffness, was associated with both traditional cardiovascular risk factors, including SBP and LVMI, but also non-traditional risk factors such as prescription of active vitamin D analogues, suggesting a potential link between vascular calcification and arterial stiffness in haemodialysis patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Green D, Roberts PR, New DI, Kalra PA (2011) Sudden cardiac death in haemodialysis patients: an in-depth review. Am J Kidney Dis 57(6):921–929

    Article  PubMed  Google Scholar 

  2. Seliger SL, Gillen DL, Tirschwell D, Wasse H, Kestenbaum BR, Stehman-Breen CO (2003) Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol 14(10):2623–2631

    Article  PubMed  Google Scholar 

  3. Cavalcante JL, Lima JA, Redheuil A, Al-Mallah MH (2011) Aortic stiffness: current understanding and future directions. J Am Coll Cardiol 57(14):1511–1522

    Article  PubMed  Google Scholar 

  4. Sigrist MK, Chiarelli G, Levin A, Romann A, Weber C (2010) Pulse wave velocity measurements are reproducible in multiple trained observers: a short report. Nephron Clin Pract 116(1):c60–c64

    Article  CAS  PubMed  Google Scholar 

  5. Covic A, Gusbeth-Tatomir P, Goldsmith DJ (2005) Arterial stiffness in renal patients: an update. Am J Kidney Dis 45(6):965–977

    Article  PubMed  Google Scholar 

  6. Horváth IG, Németh A, Lenkey Z, Alessandri N, Tufano F, Kis P, Gaszner B, Cziráki A (2010) Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity. J Hypertens 28(10):2068–2075

    Article  PubMed  Google Scholar 

  7. Davies JM, Bailey MA, Griffin KJ, Scott DJ (2012) Pulse wave velocity and the non-invasive methods used to assess it: Complior, SphygmoCor, Arteriograph and Vicorder. Vascular 20(6):342–349

    Article  PubMed  Google Scholar 

  8. Vernon K, Peasegood J, Riddell A, Davenport A (2010) Dialyzers designed to increase internal filtration do not result in significantly increased platelet activation and thrombin generation. Nephron Clin Pract 117(4):c403–c408

    Article  PubMed  Google Scholar 

  9. Davenport A (2009) Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments. Nephrology (Carlton) 14:455–461

    Article  CAS  Google Scholar 

  10. Willicombe MK, Vernon K, Davenport A (2010) Embolic complications from central venous haemodialysis catheters used with hypertonic citrate locking solution. Am J Kidney Dis 55(2):348–351

    Article  PubMed  Google Scholar 

  11. Sandhu E, Crawford C, Davenport A (2012) Weight gains and increased blood pressure in outpatient hemodialysis patients due to change in acid dialysate concentrate supplier. Int J Artif Organs 35(9):642–647

    CAS  PubMed  Google Scholar 

  12. Booth J, Pinney J, Davenport A (2010) N-terminal proBNP-marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? Clin J Am Soc Nephrol 5(6):1036–1040

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Davenport A (2012) Changes in N-terminal pro-brain natriuretic peptide correlate with fluid volume changes assessed by bioimpedance in peritoneal dialysis patients. Am J Nephrol 36(4):371–376

    Article  CAS  PubMed  Google Scholar 

  14. Moran N, Buscombe J, Davenport A (2008) Predicting cardiac events using adenosine triphosphate myocardial perfusion scintography in renal transplant candidates. J Nephrol Renal Transplant 1:41–52

    Google Scholar 

  15. Levin NW, Kotanko P, Eckardt KU, Kasiske BL, Chazot C, Cheung AK, Redon J, Wheeler DC, Zoccali C, London GM (2010) Blood pressure in chronic kidney disease stage 5D-report from a kidney disease: improving global outcomes controversies conference. Kidney Int 77(4):273–284

    Article  PubMed  Google Scholar 

  16. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W (2006) American Society of Echocardiography’s Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 7(2):79–108

    Article  PubMed  Google Scholar 

  17. Davenport A. Differences in prescribed Kt/V and delivered haemodialysis dose—why obesity makes a difference to survival for haemodialysis patients when using a ‘one size fits all’ Kt/V target. Nephrol Dial Transplant. 2013. PMID: 23787543

  18. Nemcsik J, Egresits J, El Hadj Othmane T, Fekete BC, Fodor E, Szabó T, Járai Z, Jekkel C, Kiss I, Tislér A (2009) Validation of arteriograph—a new oscillometric device to measure arterial stiffness in patients on maintenance haemodialysis. Kidney Blood Press Res 32(3):223–229

    Article  PubMed  Google Scholar 

  19. The Reference Values for Arterial Stiffness’ Collaboration (2010) Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’. Eur Heart J 31(19):2338–2350

    Article  PubMed Central  Google Scholar 

  20. Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG (2009) Relationship between vascular calcification, arterial stiffness and bone mineral density in a cross-sectional study of prevalent Australian haemodialysis patients. Nephrology (Carlton) 14(1):105–112

    Article  Google Scholar 

  21. Utescu MS, Couture V, Mac-Way F, De Serres SA, Marquis K, Larivière R, Desmeules S, Lebel M, Boutouyrie P, Agharazii M (2013) Determinants of progression of aortic stiffness in haemodialysis patients: a prospective longitudinal study. Hypertension 62(1):154–160

    Article  CAS  PubMed  Google Scholar 

  22. Celik G, Demirci MS, Tumuklu M, Ascı G, Sipahi S, Toz H, Bascı A, Ok E (2011) Factors related to pulse wave velocity and augmentation index in chronic haemodialysis patients. Ren Fail 33(10):957–963

    Article  PubMed  Google Scholar 

  23. Kuang DW, Li CL, Kuok UI, Cheung K, Lio WI, Xin J (2012) Risk factors associated with brachial-ankle pulse wave velocity among peritoneal dialysis patients in Macao. BMC Nephrol 13:143. doi:10.1186/1471-2369-13-143

    Article  PubMed Central  PubMed  Google Scholar 

  24. Korsheed S, Eldehni MT, John SG, Fluck RJ, McIntyre CW (2011) Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function. Nephrol Dial Transplant 26(10):3296–3302

    Article  PubMed  Google Scholar 

  25. Shigenaga A, Tamura K, Dejima T, Ozawa M, Wakui H, Masuda S, Azuma K, Tsurumi-Ikeya Y, Mitsuhashi H, Okano Y, Kokuho T, Sugano T, Ishigami T, Toya Y, Uchino K, Tokita Y, Umemura S (2009) Effects of angiotensin II type 1 receptor blocker on blood pressure variability and cardiovascular remodelling in hypertensive patients on chronic peritoneal dialysis. Nephron Clin Pract 112(1):c31–c40

    Article  CAS  PubMed  Google Scholar 

  26. Jung JY, Hwang YH, Lee SW, Lee H, Kim DK, Kim S, Oh YG, Yang J, Joo KW, Ahn C, Oh KH (2010) Factors associated with aortic stiffness and its change over time in peritoneal dialysis patients. Nephrol Dial Transplant 25(12):4041–4048

    Article  PubMed  Google Scholar 

  27. Noordzij M, Cranenburg EM, Engelsman LF, Hermans MM, Boeschoten EW, Brandenburg VM, Bos WJ, Kooman JP, Dekker FW, Ketteler M, Schurgers LJ, Krediet RT, Korevaar JC, NECOSAD Study Group (2011) Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant 26(5):1662–1669

    Article  PubMed  Google Scholar 

  28. Shroff RC, Shanahan CM (2007) The vascular biology of calcification. Semin Dial 20(2):103–109

    Article  PubMed  Google Scholar 

  29. London GM, Marchais SJ, Guérin AP, Boutouyrie P, Métivier F, de Vernejoul MC (2008) Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 19(9):1827–1835

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Townsend RR, Chirinos JA, Parsa A, Weir MA, Sozio SM, Lash JP, Chen J, Steigerwalt SP, Go AS, Hsu CY, Rafey M, Wright JT Jr, Duckworth MJ, Gadegbeku CA, Joffe MP, Chronic Renal Insufficiency Cohort Investigators (2010) Central pulse pressure in chronic kidney disease: a chronic renal insufficiency cohort ancillary study. Hypertension 56(3):518–524

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Jung JY, Hwang YH, Lee SW, Lee H, Kim DK, Kim S, Oh YG, Yang J, Joo KW, Ahn C, Oh KH. Factors associated with aortic stiffness and its change over time in peritoneal dialysis patients

  32. Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, Inaba M, Fukumoto S, Ishimura E, Miki T, Tabata T, Nishizawa Y (2004) Lower risk for cardiovascular mortality in oral 1α-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant 19:179–184

    Article  CAS  PubMed  Google Scholar 

  33. Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R (2003) Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349(5):446–456

    Article  CAS  PubMed  Google Scholar 

  34. Cozzolino M, Mehmeti F, Ciceri P, Volpi E, Stucchi A, Brenna I, Cusi D (2011) The effect of paricalcitol on vascular calcification and cardiovascular disease in uremia: beyond PTH control. Int J Nephrol 2011:269060. doi:10.4061/2011/269060

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

Funding—Royal Free hospital.

Conflict of interest

The authors have no conflict of interest.

Author information

Authors and Affiliations

  1. UCL Centre for Nephrology, Royal Free Hospital, University College London Medical School, Rowland Hill Street, London, NW3 2PF, UK

    Evangelina Charitaki & Andrew Davenport

Authors
  1. Evangelina Charitaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew Davenport
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew Davenport.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Charitaki, E., Davenport, A. Aortic pulse wave velocity in haemodialysis patients is associated with the prescription of active vitamin D analogues. J Nephrol 27, 431–437 (2014). https://doi.org/10.1007/s40620-014-0040-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-014-0040-9

Keywords

Search

Navigation